OXYCONTIN®

DRUG3 trials

Sponsors

Mundipharma (China) Pharmaceutical Co. Ltd

Conditions

Chronic Pain

Phase 1

OTR Tablet 40 mg Fasted-state Bioequivalence Study

CompletedNCT03398278

Mundipharma (China) Pharmaceutical Co. LtdChronic Pain

Start: 2017-06-30End: 2018-03-20Updated: 2020-01-31

OTR Tablet 40 mg Fed-state Bioequivalence Study

CompletedNCT03398330

Mundipharma (China) Pharmaceutical Co. LtdChronic Pain

Start: 2017-03-16End: 2017-11-06Updated: 2019-11-15

OTR Tablet 10 mg Fasted-state Bioequivalence Study

CompletedNCT03403504

Mundipharma (China) Pharmaceutical Co. LtdChronic Pain

Start: 2017-02-01End: 2017-09-07Updated: 2020-01-31